Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122584) titled 'Intervention Study of Christensenella minuta SJ-2 in Individuals with Prediabetes' on April 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University Third Hospital
Condition:
prediabetes
Intervention:
treatment group:The treatment group will receive a daily dose of Christensenella minuta SJ-2 preparation containing 10^10 CFU of live bacteria for 12 weeks.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-17
Target Sample Size: treatment group:75;control group:75;
Countries of Recruitment:
China
To know more, visit https://www.ch...